10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Efficacy and safety of mepolizumab in Japanese patients with severe eosinophilic asthma.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          The MENSA trial assessed the efficacy and safety of mepolizumab in patients with severe eosinophilic asthma. This report describes the efficacy and safety of mepolizumab in Japanese patients from MENSA.

          Related collections

          Author and article information

          Journal
          Allergol Int
          Allergology international : official journal of the Japanese Society of Allergology
          Elsevier BV
          1440-1592
          1323-8930
          Jul 2017
          : 66
          : 3
          Affiliations
          [1 ] Department of Allergy, Fukuoka National Hospital, Fukuoka, Japan. Electronic address: t-shimoda@mfukuoka2.hosp.go.jp.
          [2 ] Department of Pediatrics, Fukuoka National Hospital, Fukuoka, Japan.
          [3 ] Development and Medical Affairs Division, GSK K.K., Tokyo, Japan.
          [4 ] Clinical Statistics, GSK, UK.
          [5 ] Respiratory Therapeutic Area, GSK, USA.
          Article
          S1323-8930(16)30175-7
          10.1016/j.alit.2016.11.006
          28110896
          9ee22aae-fbe1-49ac-a86d-d5e214fae24b
          History

          Asthma,Treatment efficacy,Safety,Placebo,Mepolizumab
          Asthma, Treatment efficacy, Safety, Placebo, Mepolizumab

          Comments

          Comment on this article